Yasin Memari

8.6k total citations
12 papers, 447 citations indexed

About

Yasin Memari is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yasin Memari has authored 12 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Yasin Memari's work include Cancer Genomics and Diagnostics (5 papers), Genomics and Rare Diseases (3 papers) and CRISPR and Genetic Engineering (3 papers). Yasin Memari is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genomics and Rare Diseases (3 papers) and CRISPR and Genetic Engineering (3 papers). Yasin Memari collaborates with scholars based in United Kingdom, United States and Portugal. Yasin Memari's co-authors include Serena Nik‐Zainal, Cherif Badja, Richard Durbin, Helen Davies, Xueqing Zou, Tauanne Dias Amarante, Ilias Georgakopoulos‐Soares, Ching Chiek Koh, Sascha Sauer and Georg F. Hoffmann and has published in prestigious journals such as Nature Communications, Nature Genetics and Bioinformatics.

In The Last Decade

Yasin Memari

10 papers receiving 441 citations

Peers

Yasin Memari
Suan Sun China
Fiona M. Behan United Kingdom
Martijn Koppens Netherlands
Yan Xiao China
Jeroen M. Bugter Netherlands
Yasin Memari
Citations per year, relative to Yasin Memari Yasin Memari (= 1×) peers Anna Maria Bello

Countries citing papers authored by Yasin Memari

Since Specialization
Citations

This map shows the geographic impact of Yasin Memari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasin Memari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasin Memari more than expected).

Fields of papers citing papers by Yasin Memari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasin Memari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasin Memari. The network helps show where Yasin Memari may publish in the future.

Co-authorship network of co-authors of Yasin Memari

This figure shows the co-authorship network connecting the top 25 collaborators of Yasin Memari. A scholar is included among the top collaborators of Yasin Memari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasin Memari. Yasin Memari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Koh, Ching Chiek, Arjun S. Nanda, Andrea Degasperi, et al.. (2025). A redefined InDel taxonomy provides insights into mutational signatures. Nature Genetics. 57(5). 1132–1141.
2.
Campos, Ana Bosch, Srinivas Veerla, Frida Rosengren, et al.. (2025). Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer. Nature Communications. 16(1). 2208–2208. 3 indexed citations
4.
Koh, Ching Chiek, Firas Sadiyah, Cherif Badja, et al.. (2023). The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells. Nature Genetics. 56(1). 23–26. 30 indexed citations
5.
Rouhani, Foad J., Xueqing Zou, Petr Danecek, et al.. (2022). Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nature Genetics. 54(9). 1406–1416. 47 indexed citations
6.
Dettwiler, Martina, Kerstin Hahn, Anna Letko, et al.. (2022). A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer. Scientific Reports. 12(1). 18051–18051. 21 indexed citations
7.
Meijer, Titia G., Luan Nguyen, Arne van Hoeck, et al.. (2022). Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests. Oncogene. 41(26). 3498–3506. 10 indexed citations
8.
Nik‐Zainal, Serena, Yasin Memari, & Helen Davies. (2020). Holistic cancer genome profiling for every patient. Swiss Medical Weekly. 150(304). w20158–w20158. 4 indexed citations
9.
Degasperi, Andrea, Tauanne Dias Amarante, Jan Czarnecki, et al.. (2020). A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies. Nature Cancer. 1(2). 249–263. 127 indexed citations
10.
Haute, Lindsey Van, Sabine Dietmann, Laura S. Kremer, et al.. (2016). Deficient methylation and formylation of mt-tRNAMet wobble cytosine in a patient carrying mutations in NSUN3. Nature Communications. 7(1). 12039–12039. 190 indexed citations
11.
Jerončić, Ana, Yasin Memari, Graham R. S. Ritchie, et al.. (2016). Whole-exome sequencing in an isolated population from the Dalmatian island of Vis. European Journal of Human Genetics. 24(10). 1479–1487. 7 indexed citations
12.
Geihs, Matthias, Yan Yan, Klaudia Walter, et al.. (2015). An interactive genome browser of association results from the UK10K cohorts project. Bioinformatics. 31(24). 4029–4031. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026